Precision BioSciences Inc
NASDAQ:DTIL

Watchlist Manager
Precision BioSciences Inc Logo
Precision BioSciences Inc
NASDAQ:DTIL
Watchlist
Price: 4.9 USD -2.58%
Market Cap: 51.7m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+21%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

DTIL Price Targets Summary
Precision BioSciences Inc

Wall Street analysts forecast DTIL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DTIL is 21.93 USD with a low forecast of 13.13 USD and a high forecast of 31.5 USD.

DTIL Lowest Forecast
Wall Street Target
13.13 USD
168% Upside
DTIL Average Forecast
Wall Street Target
21.93 USD
348% Upside
DTIL Highest Forecast
Wall Street Target
31.5 USD
543% Upside
Lowest
Price Target
13.13 USD
168% Upside
Average
Price Target
21.93 USD
348% Upside
Highest
Price Target
31.5 USD
543% Upside
Precision BioSciences Inc Competitors:
Price Targets
87S
Roivant Sciences Ltd
60% Upside
PRQR
ProQR Therapeutics NV
388% Upside
IMNM
Immunome Inc
165% Upside
CPRX
Catalyst Pharmaceuticals Inc
46% Upside
87S
Roivant Sciences Ltd
60% Upside
PRQR
ProQR Therapeutics NV
388% Upside
IMNM
Immunome Inc
165% Upside
CPRX
Catalyst Pharmaceuticals Inc
46% Upside
TNG
Transgene SA
74% Upside
005690
Pharmicell Co Ltd
49% Upside
ALT
Altimmune Inc
222% Upside
BRNS
Barinthus Biotherapeutics PLC
408% Upside

Revenue
Forecast

Revenue Estimate
Precision BioSciences Inc

For the last 7 years the compound annual growth rate for Precision BioSciences Inc's revenue is 40%. The projected CAGR for the next 3 years is -23%.

40%
Past Growth
-23%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Precision BioSciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Precision BioSciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss
What are analyst estimates?

See Also

Summary
DTIL intrinsic value, competitors valuation, and company profile.
DCF Valuation
DTIL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DTIL stock valuation using valuation multiples.
Wall Street Estimates
DTIL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DTIL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DTIL's stock price target?
Price Target
21.93 USD

According to Wall Street analysts, the average 1-year price target for DTIL is 21.93 USD with a low forecast of 13.13 USD and a high forecast of 31.5 USD.

What is Precision BioSciences Inc's Revenue forecast?
Projected CAGR
-23%

For the last 7 years the compound annual growth rate for Precision BioSciences Inc's revenue is 40%. The projected CAGR for the next 3 years is -23%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 262,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.